CREDIT AGREEMENT Dated as of April 19, 2007, Among KING PHARMACEUTICALS, INC., THE LENDERS NAMED HEREIN, CREDIT SUISSE, CAYMAN ISLANDS BRANCH, as Administrative Agent, as Collateral Agent and as Swingline Lender, BANK OF AMERICA, N.A., and UBS...Credit Agreement • August 7th, 2007 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
CREDIT AGREEMENT dated as of April 19, 2007 (as amended, supplemented or otherwise modified from time to time, this “Agreement”), among KING PHARMACEUTICALS, INC., a Tennessee corporation (the “Borrower”); the Lenders (as defined in Article I); CREDIT SUISSE, a bank organized under the laws of Switzerland, acting through its Cayman Islands Branch, as administrative agent and collateral agent for the Lenders (in such capacity, the “Administrative Agent” and the “Collateral Agent”), and as swingline lender (in such capacity, the “Swingline Lender”), Bank of America, N.A. and UBS Securities LLC, as co-syndication agents (in such capacity, “Co-Syndication Agents”); Citigroup Global Markets Inc., Wachovia Bank, National Association and The Royal Bank of Scotland plc, as co-documentation agents (in such capacity, the “Co-Documentation Agents”); U.S. Bank National Association, as managing agent (in such capacity, the “Managing Agent”); and the Issuing Banks (as defined in Article I).
